A phase 1 trial evaluating BWV-201
Latest Information Update: 24 Aug 2023
At a glance
- Drugs BWV-201 (Primary)
- Indications Pneumonia
- Focus Adverse reactions
Most Recent Events
- 09 Dec 2022 New trial record
- 06 Dec 2022 According to a Blue Water Vaccines media release, Company will host an online Key Opinion Leader (KOL) event, Dr. Fattom will present the current action plan for BWV-201 development, including milestones and timelines to reach a Phase I clinical trial.